Skip to main content
Linical Co., Ltd. logo

Linical Co., Ltd. — Investor Relations & Filings

Ticker · 2183 ISIN · JP3974530002 T Professional, scientific and technical activities
Open in API
Filings indexed 60 across all filing types
Latest filing 2022-06-24 Audit Report / Informat…
Country JP Japan
Listing T 2183

About Linical Co., Ltd.

https://www.linical.com/

Linical is a global Contract Research Organization (CRO) providing a full spectrum of drug development services to biopharmaceutical companies. The company supports clinical trials from early-stage research to large-scale, multinational studies (Phase I-IV). Its services include clinical trial strategy, consulting, monitoring, and quality control. Linical focuses on a collaborative approach to guide clients through the clinical development process, aiming to expedite timelines and achieve enrollment goals without compromising quality.

Recent filings

Filing Released Lang Actions
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under Article 24-4-2 of the Financial Instruments and Exchange Act of Japan. This is a mandatory document that accompanies the Annual Securities Report (Yuuka Shouken Houkokusho) to confirm the accuracy of the financial statements. Since it is a regulatory filing required by law to accompany the annual report but is not the annual report itself, and does not fit into other specific categories like 'Audit Report' or 'Management Report', it falls under the 'Regulatory Filings' (RNS) category. FY 2022
2022-06-24 Japanese
有価証券報告書－第17期(令和3年4月1日－令和4年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuuka Shouken Houkokusho' (Securities Report), which is the Japanese equivalent of a 10-K. It contains comprehensive financial data, management indicators, and business information for the fiscal year ending March 31, 2022. It is a formal regulatory filing submitted to the Kinki Finance Bureau under the Financial Instruments and Exchange Act. FY 2022
2022-06-24 Japanese
四半期報告書－第17期第3四半期(令和3年10月1日－令和3年12月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Linical Co., Ltd., covering the third quarter of the 17th fiscal period (October 1, 2021, to December 31, 2021). It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement, along with management's analysis of financial results. This fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data for a period shorter than a full fiscal year. 9M 2022
2022-02-14 Japanese
四半期報告書－第17期第2四半期(令和3年7月1日－令和3年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by Linical Co., Ltd. in accordance with the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements, management analysis (MDA), and auditor review information for the second quarter of the fiscal year ending March 31, 2022. As it is a comprehensive financial report for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. Q2 2022
2021-11-15 Japanese
四半期報告書－第17期第1四半期(令和3年4月1日－令和3年6月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Linical Co., Ltd. covering the first quarter of the 17th fiscal period (April 1, 2021, to June 30, 2021). It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement, as well as management analysis and notes on accounting policies. This fits the definition of an Interim/Quarterly Report (IR). Q1 2022
2021-08-13 Japanese
内部統制報告書－第16期(令和2年4月1日－令和3年3月31日)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act (金融商品取引法) in Japan. This type of report details the company's internal control framework, evaluation scope, and results regarding financial reporting. Since it is a specific regulatory filing concerning internal controls and does not fit into categories like 10-K (Annual Report) or IR (Interim Report), it falls under the 'Regulatory Filings' category.
2021-06-25 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.